Introduction 36
Serious Streptococcus pneumoniae infections, including pneumonia, 37 bacteremia, and meningitis, are a major cause of morbidity and mortality among 38 older adults. [1] [2] [3] Since the 1980s, vaccines to prevent pneumococcal disease 39 have been used on a global scale to mitigate the risks associated with these 40 alcoholism + CLD (OR 6.20, ), Age + CLD + IC (OR 42.90, 390.98), alcoholism + CLD + DM + IC (OR 32.10, 3), age + CLD + 151 CRD + IC + smoking (OR 16.07, , and Age + Alcoholism + CLD + 152 CRD + IC + smoking (OR 21.40, were the strongest predictors of 153 mortality for those with two, three, four, five, or six risk factors, respectively ( Figure  154 2). Results for all stacked risks are available in Appendix A. 155
156

Discussion 157
We quantified the impact of stacking pneumococcal disease risk factors on 158
30-day mortality in unvaccinated older Veterans with serious pneumococcal 159
infections. Of the 8 individual risk factors assessed, 37.5% of them significantly 160 increased the risk of death and of the 247 stacked risks, 35% significantly 161 increased the risk of death. Current literature regarding predictors of mortality in 162 the setting of pneumococcal disease is primarily related to the impact of individual 163 predictors, particularly in the immunocompromised population, as well as those 164 with invasive pneumococcal disease. [8] [9] [10] [11] [12] [13] [14] [15] [16] However, there is a dearth of 165 information regarding outcomes of patients with multiple risk factors for 166 pneumococcal disease and the subsequent impact of this risk stacking.
To our 167 knowledge, this study is the first to analyze the effect of risk factor combinations 168 on mortality. As the current body of literature strongly supports the association 169 between vaccination preventing invasive infections and subsequent mortality in the 170 setting of individual risk factors, the importance of disease prevention in patients 171 with multiple risk factors cannot be overstated. [1-3, 8, 10, 16] Mortality increased in each phase of risk stacking, up to six risk factors. 173
Compared to patients with none of the eight risk factors for the development of 174 pneumococcal disease, those with two risk factors were twice as likely to die at 30 175 days. Those with six risk factors were more than four times as likely to die 176 compared to those with no risk factors, and almost three times more likely to die 177 as those with a single risk factor. No seven or eight risk factor combinations were 178 statistically significant. However, this is likely due to smaller sample sizes in the 179 seven (n=16) and eight (n=6) stacked risk groups. As pointed out in a recent risk 180 stacking study, combining the effects of two independent risk factors as odds ratios 181 leads to a multiplicative effect, as odds ratios are calculated on a log scale. [5, 17] 182
Risk factors that are not entirely independent, however, may not be multiplicative. 183
Several risk factors we analyzed may often be seen together, including alcohol 184 abuse and liver disease, as well as smoking and respiratory and/or heart disease. 185
Our results demonstrated that as the odds ratio increased as risk factors were 186 stacked. However, the increased risk was not multiplicative, as would be expected 187 in the presence of related conditions. 188
Interestingly, smoking was associated with a lower risk of mortality in our 189 study. However, it should be noted that these were also individuals without any of 190 the other risk factors for pneumococcal disease, including heart disease or 191 respiratory disease, which are well-established consequences of smoking and also 192 contribute to mortality. Furthermore, we were unable to quantify the degree to 193 which individuals smoked. To be considered a smoker, documentation of smoking 194 cessation counseling, use of smoking cessation medication, or an ICD-9 diagnosiscode within one year were necessary. As such, these patients may not have been 196 smokers at the time of infection. Collectively, these caveats require that the 197 association between smoking and risk of mortality within our study be interpreted 198
The results of our study demonstrate the impact of increasing numbers of 200 pneumococcal disease risk factors on mortality among patients with serious 201 pneumococcal infections. Once individuals develop a pneumococcal infection, 202 there is a lasting negative impact. A recent study within the Veteran population 203 found that patients with pneumococcal pneumonia who survived at least 30 days 204 beyond infection had increased mortality compared to the expected survival for the 205 average Veteran with similar demographics for up to ten years after recovering 206 from the infection.
[18] Furthermore, decreases in survival at ten years ranged from 207 15% to 50% according to increases in pneumonia severity index (PSI), which 208 accounts for risk factors also assessed in our study, including age, cardiac 209 disease, and hepatic dysfunction. [18, 19] As such, disease prevention may have 210 an extended positive impact on mortality. 211 Pneumococcal vaccination may be particularly important in patients with 212 multiple risk factors for pneumococcal disease. While the ACIP already 213 recommends that individuals with the risk factors assessed in our study be 214 vaccinated to prevent the development of pneumococcal disease, many adults 215 remain unvaccinated. [1, 3] This may be due, in part, to a lack of a focused strategy 216 for identifying those most at risk for poor outcomes. A study of 1,177 patients who 217 developed invasive pneumococcal disease and also had an indication for thepolysaccharide pneumococcal vaccination demonstrated that 52% were 219 unvaccinated, and that 92% of these unvaccinated individuals had at least one 220 opportunity to receive the vaccination in the 2 years prior to infection. Multivariate 221 analysis revealed that alcohol abuse, metastatic malignancy, and those ≥ 65 years 222 of age with no other indication were predictive of being unvaccinated, while 223 chemotherapy and non-HIV immune dysfunction were predictive of previous 224 vaccination. [20] 225
According to current ACIP pneumococcal vaccination recommendations, 226 patients in our study with cardiac, respiratory, and hepatic disease, along with 227 those who smoke, and have diabetes mellitus or alcoholism would have been 228 eligible to receive the 23-valent, pneumococcal polysaccharide vaccine (PPSV-229 23). In addition, those 65 years of age and older, and those with 230 immunocompromising conditions are recommended to receive both the PPSV-23 231 and the 13-valent, pneumococcal conjugate vaccine (PCV-13). [3, 21] Further, all 232 children 6 weeks and older are currently recommended to receive PCV-13 (PCV-233 7 during our study period), thereby impacting development of pneumococcal 234 disease at the population level through herd immunity. [22, 23] In the general 235 population, pneumococcal vaccination, particularly with the conjugate vaccines, 236 has been associated with substantial reductions in disease incidence through 237 indirect protection.
[23] However, the impact of herd immunity in the older Veteran 238 population remains unclear, and further studies are needed to determine if these 239 findings are consistent in this high-risk population. 240
Considering that each additional risk factor in our study increased the risk 241 of mortality by 55% in the presence of pneumococcal disease, thorough evaluation 242 of a patient's medical history must be performed to ensure that, barring any 243 contraindications, all individuals with these risk factors are vaccinated. 244
Furthermore, it is important to note that the greatest increase between stacked 245 combinations occurred as patients went from two to three risk factors. Interestingly, 246 our findings are consistent with two other risk stacking studies assessing the risk 247 of developing pneumococcal disease, which showed that the greatest increase in 248 the risk of disease development occurred when increasing from two to three 249 disease states present. [6, 21] Increases in disease development ranged from 67% 250 to 265% moving from two to three disease states across all age ranges. [6, 24] As 251 such, our study provides further evidence that risk stacking poses a substantial 252 threat in older adults, in whom multiple, chronic disease states are common. [1, 6, 253 25] Furthermore, the results of our study may assist future efforts to increase 254 pneumococcal vaccination by providing healthcare practitioners with an estimate 255 of the quantified risk of mortality for patients with different combinations of risk 256 factors for developing pneumococcal disease. 257
Limitations of our study included the assessment of risk factors identified by 258 ACIP as necessitating pneumococcal vaccination. However, there may be other 259 conditions, or combinations of conditions, that collectively increase the risk of 260 mortality in the setting of pneumococcal disease which were not assessed in our 261 study. We utilized ICD-9 diagnosis to identify disease states, allowing for the 262 possibility of misclassification bias due to potential inaccuracies. Also, our studylikely underestimated the true number of patients with pneumococcal pneumonia, 264 as we only included patients with a positive sputum culture and ICD-9 diagnosis 265 code. Further, pneumococcal pneumonia may have been the source for some 266 pneumococcal bacteremias, but without positive respiratory cultures, was not 267 categorized as such Next, patients with multiple episodes of pneumococcal 268 infection that were included in the study multiple times may have had a different 269 risk profile than those with a single episode of infection. However, this impact is 270 likely negligible, as the vast majority of patients only had one episode of infection 271 (9,730 infections in 9,468 patients). Determining the risk of mortality in patients 272 with more than six stacked risk factors was limited by small sample sizes within 273 these groups. However, we believe the risk of mortality to likely be much higher 274 than healthy individuals, as mortality increased in stacked risk factor groups with 275 larger numbers. Next, as odds ratios only approximate relative risk, actual mortality 276 risk may differ. It should also be noted that our analysis did not specifically adjust 277 for pneumonia disease severity, such as with the Pneumonia Severity Index score. 278
However, given that many of the risk factors included in our study are also part of 279 this severity index, it is likely that pneumococcal disease severity also increased 280 with the number of stacked risks.
[26] Lastly, as we studied an older Veteran 281 population, generalizability to the U.S. population as a whole is limited. 282
In unvaccinated older Veterans with serious pneumococcal disease, the 286 presence of multiple ACIP risk factors for developing pneumococcal disease was 287 associated with higher 30-day all-cause mortality. The more indications for 288 vaccination present, the greater the risk of death, which was almost three times 289 higher among those with six stacked risk factors as opposed to a single risk factor. 290
As multiple risk factors for pneumococcal disease are common among older 291 adults, effective vaccination strategies for the prevention of infection are needed. n/a n/a Age + Alcoholism + CHD + CLD + DM + Smoking < 5 0 n/a n/a Age + Alcoholism + CHD + CLD + IC + Smoking 0 < 5 n/a n/a Age + Alcoholism + CHD + CRD + DM + IC 0 0 n/a n/a Age + Alcoholism + CHD + CRD + 
Less Mortality Risk Greater Mortality Risk
